| |
TTD
Drug ID:
DAP000898
| Drug
Information |
| Name | Mephentermine | | Synonyms | Wyfentermina; Wyamine; EINECS 202-901-6; BRN 1363850; Mephenterdrinum; Mefentermin; 2-Methyl-2-methylamino-1-phenylpropane; Mephetedrine; Spectrum4_000188; Mephentermine [INN:BAN]; CAS-1212-72-2; KBio2_002091; Mefentermina; SPBio_000608; Vialin; HSDB 2172; Benzeneethanamine, N,.alpha.,.alpha.-trimethyl-; Spectrum3_001220; BSPBio_002640; KBioGR_000735; N-Methyl-omega-phenyl-tert-butylamine; NCGC00016570-03; WY-585; Mefenterdrin; N-Methyl-omega-phenyl-t-butylamine; N-Methylphentermine; N,2-dimethyl-1-phenylpropan-2-amine; KBio2_007227; NINDS_000229; 2-Methylamino-2-methyl-1-phenylpropane; KBio3_002140; SPBio_002591; LS-103737; Spectrum_001611; DivK1c_000229; AC1L1GGT; Prestwick0_000726; Prestwick3_000726; Spectrum2_000474; Mephenterminum [INN-Latin]; Prestwick1_000726; NCGC00016570-01; 100-92-5; C07889; Benzeneethanamine, N,alpha,alpha-trimethyl-; omega-Phenyl-tert-butyl-methylamine; Mephine; KBio1_000229; Mephentermine (INN); Mephenterminum; BSPBio_000652; ST075547; MEPHENTERMINE; Mefentermina [INN-Spanish]; AB00053662; Mephenterdrine; NCGC00016570-02; DB01365; 1212-72-2 (sulfate (2:1)); KBio2_004659; Prestwick2_000726; KBioSS_002091; Mephentermine Sulfate (2:1); N,alpha,alpha-Trimethylphenethylamine; Spectrum5_001008; Phenethylamine, N,alpha,alpha-trimethyl-; BPBio1_000718; Phenethylamine, N,.alpha.,.alpha.-trimethyl-; UNII-TEZ91L71V4; CID3677; D08180; N,alpha,alpha-Trimethylbenzeneethanamine; IDI1_000229 | | Indication | Hypotension | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Vasoconstrictor Agents | | CAS Number | CAS 100-92-5 | | Formular | C11H17N | | PubChem Compound ID | CID 3677. | | PubChem Substance ID | SID 10091. | | SuperDrug ATC ID | C01CA11; | | SuperDrug CAS ID | 000100925; | | Target | Alpha adrenergic receptor |  | Agonist | [2] | | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 008248 To Reference | | Ref 2 | Present state of alpha- and beta-adrenergic drugs I. The adrenergic receptor. Am Heart J. 1976 Nov;92(5):661-4. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|